186 related articles for article (PubMed ID: 27351230)
1. Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy.
Lin C; Liu H; Zhang H; He H; Li H; Shen Z; Qin J; Qin X; Xu J; Sun Y
Oncotarget; 2016 Aug; 7(31):49281-49288. PubMed ID: 27351230
[TBL] [Abstract][Full Text] [Related]
2. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of C-C motif ligand 2 associates with poor prognosis in patients with gastric cancer after gastrectomy.
Liu H; Shen Z; Wang X; Zhang H; Qin J; Qin X; Xu J; Sun Y
Tumour Biol; 2016 Mar; 37(3):3285-93. PubMed ID: 26438062
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of Siglec-8 associates with poor prognosis in patients with gastric cancer after surgical resection.
Cao Y; Liu H; Zhang H; Lin C; Li R; Zhang W; Shen Z; Xu J
Tumour Biol; 2016 Aug; 37(8):10883-91. PubMed ID: 26883254
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy.
Gu Q; Zhang J; Hu H; Tan YE; Shi S; Nian Y
PLoS One; 2015; 10(11):e0142377. PubMed ID: 26545111
[TBL] [Abstract][Full Text] [Related]
7. High expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection.
Li R; Zhang H; Liu H; Lin C; Cao Y; Zhang W; Shen Z; Xu J
Oncotarget; 2016 Apr; 7(17):23909-18. PubMed ID: 26992207
[TBL] [Abstract][Full Text] [Related]
8. Increased Expression of CSF-1 Associates With Poor Prognosis of Patients With Gastric Cancer Undergoing Gastrectomy.
Liu H; Zhang H; Shen Z; Lin C; Wang X; Qin J; Qin X; Xu J; Sun Y
Medicine (Baltimore); 2016 Mar; 95(9):e2675. PubMed ID: 26945355
[TBL] [Abstract][Full Text] [Related]
9. Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery.
Wu S; Liu H; Zhang H; Lin C; Li R; Cao Y; He H; Li H; Shen Z; Qin J; Xu J
Tumour Biol; 2016 Sep; 37(9):12635-12642. PubMed ID: 27444274
[TBL] [Abstract][Full Text] [Related]
10. IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer.
Fujisawa T; Joshi BH; Puri RK
Int J Cancer; 2012 Jul; 131(2):344-56. PubMed ID: 21858811
[TBL] [Abstract][Full Text] [Related]
11. A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients.
Zheng Z; Zhang Y; Zhang L; Li Z; Wu X; Liu Y; Bu Z; Ji J
BMC Cancer; 2016 Feb; 16():92. PubMed ID: 26873736
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy.
Hui WT; Ma XB; Zan Y; Wang XJ; Dong L
Chin Med J (Engl); 2015 Oct; 128(19):2632-7. PubMed ID: 26415802
[TBL] [Abstract][Full Text] [Related]
13. Tryptase expression as a prognostic marker in patients with resected gastric cancer.
Lin C; Liu H; Zhang H; Cao Y; Li R; Wu S; Li H; He H; Xu J; Sun Y
Br J Surg; 2017 Jul; 104(8):1037-1044. PubMed ID: 28542986
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of computed tomography radiomics features in patients with gastric cancer following curative resection.
Li W; Zhang L; Tian C; Song H; Fang M; Hu C; Zang Y; Cao Y; Dai S; Wang F; Dong D; Wang R; Tian J
Eur Radiol; 2019 Jun; 29(6):3079-3089. PubMed ID: 30519931
[TBL] [Abstract][Full Text] [Related]
15. IL-13Rα2 gene expression is a biomarker of adverse outcome in patients with adrenocortical carcinoma.
Kumar A; Bellayr IH; Singh HS; Puri RK
PLoS One; 2021; 16(2):e0246632. PubMed ID: 33591997
[TBL] [Abstract][Full Text] [Related]
16. CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients.
Cao Y; Liu H; Zhang H; Lin C; Li R; Wu S; Li H; He H; Zhang W; Xu J
Oncotarget; 2017 Mar; 8(12):20328-20339. PubMed ID: 27780937
[TBL] [Abstract][Full Text] [Related]
17. A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma.
Kim Y; Spolverato G; Ejaz A; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby D; Worhunsky D; Saunders N; Levine EA; Cho CS; Maithel SK; Pawlik TM
Ann Surg Oncol; 2015; 22(6):1828-35. PubMed ID: 25388061
[TBL] [Abstract][Full Text] [Related]
18. Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.
Barchi LC; Yagi OK; Jacob CE; Mucerino DR; Ribeiro U; Marrelli D; Roviello F; Cecconello I; Zilberstein B
Eur J Surg Oncol; 2016 Jan; 42(1):123-31. PubMed ID: 26365755
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of αTubulin is associated with poor prognosis in patients with pancreatic cancer after surgical resection.
Lin C; Zhao GC; Xu YD; Wang DS; Jin DY; Ji Y; Lou WH; Wu WC
Oncotarget; 2016 Sep; 7(37):60657-60664. PubMed ID: 27447976
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
